Healthcare
Live Price
Offline$32.48
+0.03% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
CymaBay Therapeutics, Inc. (CBAY) is a Healthcare stock with a market cap of $3.73B. The stock last traded around $32.48. Baseline metrics include revenue growth of 0.0%, EPS growth of +26.7%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +26.7%, free cash flow +13.4% with operating margin -327.2% and ROIC -24.9%. Valuation already assumes a fairly strong business story at price/sales 120.0. Stock Foundry combines CBAY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CBAY
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CBAY Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CBAY and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.